journal article·2013-05

A novel biocompatible drug carrier for oral delivery and controlled release of antibiotic drug: loading and release of clarithromycin as an antibiotic drug model

Elahe Moazzen, Homeira Ebrahimzadeh, Mostafa M. Amini, Omid Sadeghi

Publisher page

Abstract

In this work, a novel biocompatible carrier was designed by modification of nanoporous carbon material and synthesized by hydrothermal condensation of d-Fructose, as the carbon source, in the presence of Pluronic® F127, as the surfactant. The prepared material is completely biocompatible and suitable for oral drug delivery. As this nanoporous carbon has surface decorated hydroxyl groups, they are able to react with 3-aminopropyltriethoxysilane agent and produce amino-functionalized nanoporous carbon. The synthesis of amine-modified carbon nanoporous material was confirmed by X-ray powder diffraction, IR spectroscopy, elemental analysis, thermal analysis and nitrogen adsorption analysis. Clarithromycin as an active drug molecule with carbonyl and hydroxyl functional groups in chemical structure was chosen as the drug model and stored in pores of the amine-modified nanoporous carbon. Release of clarithromycin from modified nanoporous carbon was investigated in mouth and stomach pH values. The results showed that this drug carrier can transfer the drug up to stomach without any leak or release. The release time was investigated, and the results showed that the carrier is also successful for the controlled-release delivery.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesoporous Materials and Catalysis · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (18)

Show source-provided references
1. Panyam J, Labhasetwar V (2003) Adv Drug Deliv Rev 55:32910.1016/S0169-409X(02)00228-4 ↗
2. Gómez-Burgaz M, García-Ochoa B, Torrado-Santiago S (2008) Int J Pharm 359:13510.1016/j.ijpharm.2008.03.042 ↗
3. Heikkilä T, Salonen J, Tuura J, Hamdy MS, Mul G, Kumar N, Salmi T, Murzin D, Laitinen L, Kaukonen AM, Hirvonen J, Lehto V (2007) Int J Pharm 331:13310.1016/j.ijpharm.2006.09.019 ↗
4. Tang H, Guo J, Sun Y, Chang B, Ren Q, Yang W (2011) Int J Pharm 421:38810.1016/j.ijpharm.2011.10.013 ↗
5. Bose S, Tarafder S (2012) Acta Biomater 8:140110.1016/j.actbio.2011.11.017 ↗
6. Wang Y, Grayson SM (2012) Adv Drug Deliv Rev 64:85210.1016/j.addr.2012.03.011 ↗
7. Eeckman F, Moës A, Amigh K (2002) Int J Pharm 241:11310.1016/S0378-5173(02)00198-9 ↗
8. Langoth N, Kalbe J, Bernkop-Schnürch A (2003) Int J Pharm 252:14110.1016/S0378-5173(02)00638-5 ↗
9. Seong J, Jun YJ, Kim BM, Park YM, Sohn YS (2006) Int J Pharm 314:9010.1016/j.ijpharm.2006.02.009 ↗
10. Sant S, Tao SL, Fisher OZ, Xu Q, Peppas NA, Khademhosseini A (2012) Adv Drug Deliv Rev 64:49610.1016/j.addr.2011.11.013 ↗
11. Yu j, Kang S, Yoon SB, Chai G (2002) J Am Chem Soc 124:938210.1021/ja0203972 ↗
12. Choi M, Jang J (2008) J Colloid Interface Sci 325:28710.1016/j.jcis.2008.05.047 ↗
13. Guo Y, Zhao J, Zhang H, Yang Sh, Qi J, Wang Z, Xu H (2005) Dyes Pigm 66:12310.1016/j.dyepig.2004.09.014 ↗
14. Huang Y, Cai HQ, Yu T, Zhang FQ, Zhang F, Meng Y, Gu D, Wan Y, Sun XL, Tu B, Zhao D (2007) Angew Chem Int Ed 46:108910.1002/anie.200603665 ↗
15. Zhang F, Meng Y, Gu D, Yan Y, Yu C, Tu B, Zhao DJ (2005) J Am Chem Soc 127:1350810.1021/ja0545721 ↗
16. Kubo S, White RJ, Yoshizawa N, Antonietti M, Titirici M (2011) Chem Mater 23:488210.1021/cm2020077 ↗
17. Frisch MJ et al (1998) Gaussian 98. Gaussian, Pittsburgh
18. Barnes K, Liang J, Worley SD, Lee J, Broughton RM, Huang TS (2007) J Appl Polym Sci 105:230610.1002/app.26280 ↗